 Bayer FRA:BAYN received a 77.00 86.52 target price from research analysts at JPMorgan Chase Co. in a research note issued on Wednesday, Borsen Zeitung reports. The brokerage presently has a neutral rating on the healthcare companys stock. JPMorgan Chase Co.s price target would indicate a potential upside of 17.04 from the stocks current ... 